Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
Martine Humbert(AB Science (France)), Patrice Dubreuil(Centre National de la Recherche Scientifique)
Cited by 75
Related Papers
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
|PLoS ONE|2009|409
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
|Nature Communications|2017|24